• About us
• Contact

Advertisement

Organisation › Details

Sanofi Ventures EU

Sanofi Ventures is the corporate venture capital arm of Sanofi. Sanofi Ventures invests in early-stage biotech and digital health companies with innovative ideas and transformative new products and technologies of strategic interest to Sanofi. Among these areas are oncology, immunology, rare diseases, vaccines, potential cures in other core areas of Sanofi’s business footprint, and digital health solutions. *

 

	Start	2020-06-06 existent
	Group	Sanofi (Group) [since May 2011]
	Industry	venture capital
	Industry 2	pharmaceutical
	Region	Paris
	Country	France
	Street	54–56 rue de la Boétie
	City	75008 Paris
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«: Avilar Therapeutics, Inc.. (2/16/23). "Press Release: Avilar Therapeutics Increases Financing to $75 Million to Advance Pipeline of Novel Extracellular Protein Degraders". Waltham, MA.
		Record changed: 2025-04-26

Advertisement

More documents for Sanofi (Group) [since May 2011]

• [1] Recursion Pharmaceuticals, Inc.. (5/5/25). "Press Release: Recursion Reports First Quarter 2025 Financial Results and Provides Business Update". Salt Lake City, UT....
• [2] Earendil Labs. (4/17/25). "Press Release: Earendil Labs Announces Worldwide Exclusive License Agreement with Sanofi for Next-Generation Bispecific Antibodies for Autoimmune and Inflammatory Bowel Diseases". Middletown, DE....
• [3] Augustine Therapeutics N.V.. (4/9/25). "Press Release: Augustine Therapeutics Appoints Industry Veteran Pascale Witz as Chair of its Board of Directors". Leuven....
• [4] Enveda. (2/26/25). "Press Release: Enveda Gains Backing from Sanofi to Advance AI-Driven Drug Discovery to Clinical Trials Bringing Total Series C Financing to $150M". Boulder, CO....
• [5] Sanofi S.A.. (12/19/24). "Press Release: Jean-Paul Kress to Join Sanofi’s Board of Directors". Paris....
• [6] MeiraGTx Holdings plc. (8/12/24). "Press Release: MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi". London & New York, NY....
• [7] Sanofi S.A.. (5/13/24). "Press Release: Sanofi Adds over €1 Billion for Biomanufacturing to €2.5 Billion Already Committed in Major Projects in France to Support Health Sovereignty". Paris....
• [8] Sartorius AG. (5/13/24). "Press Release: Sartorius Collaborates with Sanofi to Commercialize End-to-end Platform for Downstream process intensification". Göttingen....
• [9] Owkin. (3/21/24). "Press Release: Owkin Expands Collaboration with Sanofi Leveraging AI for Drug Positioning in immunology"....
• [10] GenSight Biologics S.A.. (12/22/23). "Press Release: GenSight Biologics Appoints Laurence Rodriguez as Chief Executive Officer". Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.